Guy Villax, CEO of Hovione
In 1984, Guy Villax joined pharmaceutical services pioneer Hovione in Asia. Needing capacity to supply the US market and seeing the opportunity of raw materials from China, he built a plant in Macau. When he perceived that customers did not value the quality of Hovione’s products, he migrated the business to harder-to-make active ingredients for injectable delivery and added a services business that later grew into the company’s largest, fastest-growing and most profitable business segment.
Since being appointed CEO in 1997, Guy has continued to take Hovione from strength to strength, growing the company tenfold and reaching a business valuation of over US$1b. Each decade he reinvented the company by finding a new gap in the market to fill: when emerging small pharmas needed lab and factory space, Hovione offered its services; when new molecules were not viable because they were insoluble, the company made them into amorphous spray-dried dispersions.
Guy believes that serving patients is a privilege. Of all the new medicines approved by the US FDA since 2015, Hovione has had a role in the process development or manufacturing of 8%: cures for Hepatitis C and treatments for HIV/AIDS, cancers and cystic fibrosis. Hovione now has 1,998 team members and was the first pharmaceutical or chemical company to be certified as a B Corp.
*Information correct as of June 2021.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
EY | Assurance | Consulting | Strategy and Transactions | Tax
EY is a global leader in assurance, consulting, strategy and transactions, and tax services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
© 2020 EYGM Limited. All Rights Reserved.
This material has been prepared for general informational purposes only and is not intended to be relied upon as accounting, tax, or other professional advice. Please refer to your advisors for specific advice.
In addition to cookies that are strictly necessary to operate this website, we use the following types of cookies to improve your experience and our services: Functional cookies to enhance your experience (e.g. remember settings), Performance cookies to measure the website's performance and improve your experience, Marketing/Targeting cookies which are set by third parties with whom we execute marketing campaigns and allow us to provide you with content relevant to you.
We have detected that you have enabled the Do Not Track setting in your browser; as a result, Marketing/Targeting cookies are automatically disabled.
I decline optional cookies